Measurement of endothelial dysfunction via peripheral arterial tonometry predicts vasculogenic erectile dysfunction

Area of Science:

• Cardiovascular Medicine
• Urology
• Vascular Biology

Background:

• Endothelial cell dysfunction is a key factor in cardiovascular disease and vasculogenic erectile dysfunction (ED).
• Penile endothelial dysfunction, assessed by peripheral artery tonometry (PAT), predicts future cardiovascular events.
• Identifying men with vasculogenic ED is crucial for managing both ED and cardiovascular risk.

Purpose of the Study:

• To determine if measuring endothelial dysfunction using PAT can differentiate men with vasculogenic ED from those without.
• To investigate the utility of the reactive hyperemia index (RHI) and augmentation index (AI) in assessing vasculogenic ED.

Main Methods:

• Retrospective assessment of 142 men using patient history, penile duplex ultrasonography (US), and PAT (EndoPAT 2000).
• Vasculogenic ED was defined by peak systolic velocity (PSV) ≤ 25 cm/s post-vasodilator injection via US.
• RHI and AI were recorded using PAT.

Main Results:

• Men with ED (n=111) had significantly lower RHI (1.85 ± 0.06) compared to controls without ED (n=31, RHI 2.15 ± 0.2) (P<0.05).
• Penile duplex US confirmed vasculogenic ED in the affected group (PSV 21-22 cm/s) versus controls (PSV 39 cm/s).
• AI measurements did not differ significantly between groups.

Conclusions:

• Endothelial function measurement with EndoPAT effectively differentiates men with vasculogenic ED from those without.
• RHI serves as a non-invasive surrogate marker for assessing vasculogenic ED.
• RHI assessment can identify patients with vasculogenic ED who may have increased cardiovascular risk.